Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
639.00    12.00 (1.91%)
Bid:
640.00
Ask:
641.00
Spread: 1.00 (0.156%)
Market Cap: £709.13m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Trading Update

1 Feb 2024 07:00

RNS Number : 6024B
Barr(A.G.) PLC
01 February 2024
 

IMMEDIATE RELEASE 1 February 2024

A.G. BARR p.l.c.

("A.G. BARR" or "the Group")

Trading Update

 

A.G. BARR p.l.c., the branded multi-beverage business with a portfolio of market-leading UK brands, including IRN-BRU, Rubicon, FUNKIN and Boost.

 

Strong revenue and profit performance - positive business momentum

We are pleased to report an anticipated strong revenue and profit performance in respect of the full year ended 28 January 2024.

52 weeks ended28 January 2024

52 weeks ended29 January 2023

Growth

Group revenue

c.£400m

£317.6m

c.26%

 

Revenue is expected to be c.£400m, representing c.26% year-on-year growth and c.7.6% on a like-for-like basis, excluding the contribution from the Boost Drinks business acquired in December 2022. 

Adjusted profit before tax1 is now expected to be c.£49.5m, up 13.8% on the prior year (2022/23 : £43.5m) and slightly ahead of previous market expectations.

Despite the wet summer weather which impacted Q3 market conditions, our positive underlying brand momentum ensured a strong H2 Group performance :

? Soft Drinks - including IRN-BRU, Rubicon and Boost

Inflation in the wider soft drinks market continued to drive value growth but impacted volumes within the sector. However, our brand building and pricing strategy delivered both value and volume growth, ensuring we continue to offer consumers great tasting and affordable brands.

? FUNKIN Cocktails

Delivered a strong Q4 particularly in the off trade through an excellent performance in the ready to drink segment. While the on trade channel remains variable, with late night venues experiencing reduced footfall, reports of improved festive trading for a range of hospitality venues is encouraging as we look forward.

? MOMA Foods  

Further double-digit sales growth, supported by new business wins, most notably within the speciality coffee channel.

We continue to experience cost inflation albeit at a less significant level than in the prior year. Our supply chain capital investment programme is on track supporting the in-sourcing of the Boost and Rio brands. The associated operational leverage and synergy benefits are supporting the acceleration of our margin rebuild programme.

Roger White, Chief Executive, commented :

"All our teams across the Group have worked hard to deliver an excellent overall performance. This has been supported by continued brand investment, strong execution of our sales plans and progress across our supply chain improvement programme. We have positive momentum behind our brands and business as we enter the new financial year.

This strong trading performance, coupled with the benefits already being delivered by our margin rebuild programme, has ensured we close the year with a strong profit performance and confidence in the Group's long-term growth strategy."

For more information, please contact :

A.G. BARR Instinctif Partners

0330 390 3900 020 7457 2010/05

Roger White, Chief Executive Justine Warren

Stuart Lorimer, Finance Director Matthew Smallwood

Next update : Full Year Results - 26 March 2024

 

Note 1 : Reported profit before tax is currently expected to be c.£50.3m reflecting the release of a £0.8m prior year accrual associated with the acquisition earn-out of Boost Drinks Limited in December 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTWPURAGUPCGMG
Date   Source Headline
15th Sep 20177:00 amRNSTransaction in Own Shares
13th Sep 20177:00 amRNSTransaction in Own Shares
8th Sep 201711:28 amRNSDirector/PDMR Shareholding
8th Aug 20173:59 pmRNSDirector/PDMR Shareholding
2nd Aug 20177:00 amRNSTrading Update
28th Jul 20175:00 pmRNSClose period repurchase programme
26th Jul 20177:00 amRNSTransaction in Own Shares
25th Jul 20171:45 pmRNSDirector/PDMR Shareholding
25th Jul 20177:00 amRNSTransaction in Own Shares
24th Jul 20171:37 pmRNSDirector/PDMR Shareholding
17th Jul 20178:09 amRNSTransaction in Own Shares
14th Jul 20177:43 amRNSTransaction in Own Shares
13th Jul 201710:07 amRNSNotice of Trading Update
10th Jul 20172:21 pmRNSDirector/PDMR Shareholding
28th Jun 20177:13 amRNSTransaction in Own Shares
27th Jun 201712:14 pmRNSTransaction in Own Shares
14th Jun 20173:25 pmRNSDirector/PDMR Shareholding
14th Jun 20177:00 amRNSTransaction in Own Shares
13th Jun 20177:14 amRNSTransaction in Own Shares
12th Jun 20171:33 pmRNSDirector/PDMR Shareholding
12th Jun 20171:32 pmRNSDirector/PDMR Shareholding
12th Jun 20171:30 pmRNSDirector/PDMR Shareholding
12th Jun 20171:28 pmRNSDirector/PDMR Shareholding
8th Jun 20172:02 pmRNSDirector/PDMR Shareholding
6th Jun 20174:04 pmRNSDirector/PDMR Shareholding
31st May 201712:38 pmRNSAGM Statement
18th May 20177:00 amRNSTransaction in Own Shares
9th May 20171:20 pmRNSDirector/PDMR Shareholding
3rd May 20179:43 amRNSDirector/PDMR Shareholding
27th Apr 20174:08 pmRNSAnnual Report and Accounts and Notice of AGM
26th Apr 201712:17 pmRNSDirector/PDMR Shareholding
10th Apr 201712:12 pmRNSDirector/PDMR Shareholding
3rd Apr 20173:47 pmRNSDirector/PDMR Shareholding
28th Mar 20177:00 amRNSFinal Results
8th Mar 20172:49 pmRNSDirector/PDMR Shareholding
1st Mar 20177:00 amRNSFurther reduction of sugar across portfolio
8th Feb 20171:34 pmRNSDirector/PDMR Shareholding
1st Feb 20177:00 amRNSTrading Update
12th Jan 20177:00 amRNSNotice of Trading Update
10th Jan 20172:10 pmRNSDirector/PDMR Shareholding
9th Jan 20174:35 pmRNSPrice Monitoring Extension
9th Jan 20172:56 pmRNSDirector Declaration
13th Dec 20167:00 amRNSAnalyst Site Visit
8th Dec 201612:42 pmRNSDirector/PDMR Shareholding
14th Nov 201611:23 amRNSHolding(s) in Company
10th Nov 20162:59 pmRNSHolding(s) in Company
8th Nov 201612:42 pmRNSDirector/PDMR Shareholding
25th Oct 201611:33 amRNSDirector/PDMR Shareholding
25th Oct 201611:20 amRNSDirector/PDMR Shareholding
25th Oct 201611:19 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.